LB
LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
$34.62 -6.41% (-$2.37)
1M -29.90%
Market Cap $992.8M
P/E Ratio -
Div. Yield -
ROE 25.91%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
67 /100
Cheap P/B 2.99x
P/E N/A
EV/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 28.07%
Asset turnover 0.00x
ROE 25.91%
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 15.08x
Int. coverage N/A
Stability
21 /100
Unstable Beta 0.42x
Profitable years 0
EPS volatility 567.68%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LBRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Heather D. Turner
Employees
49
Headquarters
New York
Upcoming events
05 NOV
Earnings
Upcoming earnings report